Kenneth Wong
About Kenneth Wong
Kenneth Wong is a Manager of Pharmacology at CytomX Therapeutics, where he has worked since 2022. He has extensive experience in pharmacology, having held various roles at CytomX Therapeutics and other organizations, and he holds multiple degrees in biology, chemistry, and theology.
Current Role at CytomX Therapeutics
Kenneth Wong serves as the Manager of Pharmacology at CytomX Therapeutics, a position he has held since 2022. In this role, he oversees pharmacological studies and coordinates non-human primate pharmacokinetic studies with external vendors. Wong facilitates the integration of internal and external in vivo studies across departments, ensuring effective communication with project leads. His responsibilities also include training incoming scientists to work efficiently in the animal care facility.
Previous Experience at CytomX Therapeutics
Prior to his current role, Wong held several positions at CytomX Therapeutics. He worked as an Associate Scientist in Pharmacology from 2015 to 2019 and as a Scientist I in Pharmacology & Toxicology from 2019 to 2022. Additionally, he served as a Senior Research Associate in Pharmacology from 2012 to 2015. Throughout these roles, he contributed to the evaluation of probody molecules as potential cancer immunotherapies and probody drug conjugates.
Educational Background
Kenneth Wong has an extensive educational background in the sciences. He earned a Bachelor of Science degree in Chemistry from the University of California, Berkeley, from 1972 to 1974. He later pursued advanced studies at San Francisco State University, achieving a Master of Science in Chemistry from 1978 to 1985. Additionally, Wong obtained a Master of Arts in Cell and Molecular Biology from San Francisco State University, studying from 1990 to 1994. He also holds a Master’s Degree in Theology from Fuller Theological Seminary, which he completed from 1980 to 1983.
Experience at Arete Therapeutics
Before joining CytomX Therapeutics, Wong worked at Arete Therapeutics as a Scientist in Pharmacology for one year, from 2008 to 2009. This role contributed to his foundational experience in pharmacology, which he has built upon in subsequent positions at CytomX Therapeutics.